HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ilaria Cristofaro Selected Research

Cholinergic Agonists

1/2020The metronomic combination of paclitaxel with cholinergic agonists inhibits triple negative breast tumor progression. Participation of M2 receptor subtype.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ilaria Cristofaro Research Topics

Disease

3Neoplasms (Cancer)
03/2020 - 11/2015
3Glioblastoma (Glioblastoma Multiforme)
01/2020 - 11/2015
1Breast Neoplasms (Breast Cancer)
01/2020
1Prion Diseases (Transmissible Spongiform Encephalopathies)
07/2015
1Infections
07/2015

Drug/Important Bio-Agent (IBA)

3Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA
01/2020 - 11/2015
2Muscarinic M2 ReceptorIBA
01/2020 - 11/2015
2Muscarinic AgonistsIBA
01/2020 - 01/2018
2arecaidineIBA
01/2018 - 11/2015
2EstersIBA
01/2018 - 11/2015
1Cholinergic AgonistsIBA
01/2020
1Drug CombinationsIBA
01/2020
1Paclitaxel (Taxol)FDA LinkGeneric
01/2020
1Prion ProteinsIBA
07/2015

Therapy/Procedure

2Therapeutics
03/2020 - 01/2020